OTE

Jan 08 2026HEALTH

Small Molecules, Big Impact: Lilly's Bold Move to Tackle Inflammation

Lilly, a big name in medicine, is making a big move. They're buying Ventyx, a smaller company with a promising lineup of drugs. Ventyx's focus? Inflammation. They're working on small molecules that could treat a wide range of diseases caused by chronic inflammation. Think heart disease, brain disord

reading time less than a minute
Jan 08 2026POLITICS

Iran in a Tight Spot: Trump's Actions Stir Fears and Protests

Iran is feeling the heat as President Trump's bold moves, like the recent operation in Venezuela, have put the country on edge. With protests spreading across Iran and the government struggling to keep control, Trump's threats to take action if protesters are harmed have added to the tension. Trump

reading time less than a minute
Jan 08 2026POLITICS

House Votes to Extend Health Insurance Help

In a surprising move, the House of Representatives took a big step toward extending health insurance subsidies that expired last month. These subsidies, part of the Affordable Care Act, help about 22 million people afford their health insurance. The vote was close, with 221 in favor and 205 against

reading time less than a minute
Jan 08 2026SCIENCE

Celebrating 50 Years of Protein Exploration

Fifty years ago, a big step was taken in science. The Stanford SSRL synchrotron radiation and protein crystallography initiative started. This was a game-changer. It helped scientists see proteins in a whole new way. Over the years, this technology has grown. It has made protein crystallography fas

reading time less than a minute
Jan 07 2026HEALTH

New Hope for Kidney Disease: The Promise of ARNIs

ARNIs, or Angiotensin Receptor-Neprilysin Inhibitors, are making waves in the medical world. They're already changing the game for heart failure patients. Now, doctors are wondering if they can do the same for people with kidney disease. Neprilysin is a substance in the body. It breaks down certain

reading time less than a minute
Jan 07 2026BUSINESS

Big Pharma's Urgent Quest for New Drugs

Big Pharma companies are in a rush to buy biotech firms. Why? They face a huge problem. Many of their top-selling drugs will soon lose patent protection. This is called the "patent cliff. " By 2032, they could lose over $170 billion in sales. To avoid this, they need new drugs fast. That's where bi

reading time less than a minute
Jan 06 2026POLITICS

Iran's Economic Unrest: A Closer Look at the Growing Protests

Protests have been happening in Iran for nine days now. They started because of money problems. The currency is losing value, and prices are going up. Rights groups say at least 25 people have died. More than 1, 000 people have been arrested. These protests are not as big as the ones in 2022-23. Th

reading time less than a minute
Jan 06 2026BUSINESS

A Hotel's Shameful Refusal

A Hampton Inn in Minneapolis made headlines for the wrong reasons. This hotel, part of the Hilton family, was caught on camera turning away Department of Homeland Security (DHS) agents. The agents were in town to investigate fraud, but the hotel had other plans. They sent an email saying they wouldn

reading time less than a minute
Jan 06 2026SCIENCE

A Lifesaving Antioxidant for Brain Health

Organophosphorus (OP) compounds like paraoxon (POX) can cause serious brain damage and memory problems. Current treatments help with immediate symptoms but don't tackle the long-term brain damage. Researchers tested a special antioxidant called N-acetylcysteine-amide (AD4) on mice to see if it could

reading time less than a minute
Jan 05 2026POLITICS

Iran's Economic Woes Fuel Nationwide Unrest

Iran is in the midst of serious trouble. Protests have been going on for nine days now. They started because the economy is in bad shape. People are upset about the falling value of their money and rising prices. The protests have spread to many parts of the country. Videos show people marching in

reading time less than a minute